VanEck Biotech ETF
BBH
#1826
ETF rank
A$0.53 B
Marketcap
๐Ÿ‡บ๐Ÿ‡ธ US
Market
A$271.77
Share price
-2.02%
Change (1 day)
6.36%
Change (1 year)

Expense ratio and fees for VanEck Biotech ETF (BBH)

Expense Ratio

Expense Ratio as of May 2025: 0.35%

Gross Expense Ratio

Gross Expense Ratio as of February 2026: 0.35%

Net Expense Ratio

Net Expense Ratio as of February 2026: 0.35%